This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, Y. Articles by Lin, S.-Z. Search for Related Content PubMed PubMed Citation Articles by Wang, Y. Articles by Lin, S.-Z. Related Collections Apoptosis Growth factors/cytokines Ischemic biology - basic studies Acute Cerebral Infarction

(Stroke. 2001;32:775.)
© 2001 American Heart Association, Inc.

Original Contributions

Methamphetamine Potentiates Ischemia/Reperfusion Insults After Transient Middle Cerebral Artery Ligation

Yun Wang, MD, PhD; Teruo Hayashi, MD, PhD; Chen-Fu Chang, MD; Yung-Hsiao Chiang, MD; Li-I Tsao, PhD; Tsung-Ping Su, PhD; Cesario Borlongan, PhD Shinn-Zong Lin, MD, PhD

Correspondence to Yun Wang, MD, PhD, National Institute on Drug Abuse, I.R.P., 5500 Nathan Shock Dr, Baltimore, MD 21224. E-mail ywang{at}intra.nida.nih.gov

Background and Purpose—Previous studies have indicated that both methamphetamine (MA) and ischemia/reperfusion injuries involve reactive oxygen species formation and activation of apoptotic mechanism. That MA could have a synergistic or additive effect with stroke-induced brain damage is possible. The purpose of the present study was to investigate whether administration of MA in vivo would potentiate ischemic brain injury.

Methods—Adult CD-1 mice were pretreated with MA or saline. Each animal later was anesthetized with chloral hydrate and placed in a stereotaxic frame. A subset of animals received intracerebral administration of glial cell line–derived neurotrophic factor (GDNF). The right middle cerebral artery and bilateral carotids were transiently occluded for 45 minutes. Regional cerebral blood flow was measured by laser Doppler. Animals were sacrificed for triphenyltetrazolium chloride staining and p53 mRNA Northern blot assay after 24 hours of reperfusion. Cortical and striatal GDNF levels were assayed by ELISA.

Results—We found that pretreatment with MA increased ischemia-induced cerebral infarction. Ischemia or MA alone enhanced p53 mRNA expression. Moreover, MA potentiated expression of p53 mRNA in the ischemic mouse brain. MA pretreatment decreased GDNF levels in ischemic striatum. Intracerebral administration of GDNF before ischemia reduced MA-facilitated infarction.

Conclusions—Our data indicate that MA exacerbates ischemic insults in brain, perhaps through the inhibition of GDNF-mediated pathways and suggest that MA may antagonize endogenous neuroprotective pathways as part of its mechanism of action.

Key Words: amphetamines • apoptosis • cerebral ischemia, focal • transforming growth factors

This article has been cited by other articles:

				A. N. Westover, S. McBride, and R. W. Haley Stroke in Young Adults Who Abuse Amphetamines or Cocaine: A Population-Based Study of Hospitalized Patients Arch Gen Psychiatry, April 1, 2007; 64(4): 495 - 502. [Abstract] [Full Text] [PDF]

				D. Long and J. Young Dexamphetamine treatment in stroke QJM, September 1, 2003; 96(9): 673 - 685. [Abstract] [Full Text] [PDF]

				Y. Wang, C.-F. Chang, M. Morales, Y.-H. Chiang, B. K. Harvey, T.-P. Su, L.-I Tsao, S. Chen, and C. Thiemermann Diadenosine Tetraphosphate Protects against Injuries Induced by Ischemia and 6-Hydroxydopamine in Rat Brain J. Neurosci., August 27, 2003; 23(21): 7958 - 7965. [Abstract] [Full Text] [PDF]